ホーム>>Histone H3 (1-35) (TFA)

Histone H3 (1-35) (TFA)

カタログ番号GC62459

ヒストン H3 (1-35) TFA は、ヒストン H3 の 35 残基のペプチドです。ヒストン H3 は、真核細胞のクロマチン構造に関与する 5 つの主要なヒストンの 1 つです。

Products are for research use only. Not for human use. We do not sell to patients.

Histone H3 (1-35) (TFA) 化学構造

サイズ 価格 在庫数 個数
5 mg
$360.00
在庫あり
10 mg
$630.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com


顧客レビュー

カスタマーレビューに基づきます。

Sample solution is provided at 25 µL, 10mM.

Description of Histone H3 (1-35) (TFA)

Histone H3 (1-35) TFA is a 35-residue peptide of histone H3. Histone H3 is one of the five main histones involved in the structure of chromatin in eukaryotic cells[1].

Histone H3 is an important protein in the emerging field of epigenetics, where its sequence variants and variable modification states are thought to play a role in the dynamic and long term regulation of genes[1].

[1]. Manoj Bhasin, et al. Recognition and classification of histones using support vector machine. J Comput Biol. Jan-Feb 2006;13(1):102-12.

Chemical Properties of Histone H3 (1-35) (TFA)

Cas No. SDF
Formula C151H270F3N55O47 M.Wt 3665.15
溶解度 Water : 50 mg/mL (13.64 mM; Need ultrasonic) Storage -20°C, away from moisture
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of Histone H3 (1-35) (TFA)

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 0.2728 mL 1.3642 mL 2.7284 mL
5 mM 0.0546 mL 0.2728 mL 0.5457 mL
10 mM 0.0273 mL 0.1364 mL 0.2728 mL
  • モルアリティ計算機

  • 希釈計算機

  • Molecular Weight Calculator

質量
=
濃度
x
容積
x
MW*
 
 
 
**ストックソリューションを準備する際には、常にバイアルラベルおよび MSDS/CoA(オンラインで利用可能)で掲載された製品のロット固有分子量を使用してください。

計算

In vivo Formulation Calculator (Clear solution) of Histone H3 (1-35) (TFA)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

レビュー

Review for Histone H3 (1-35) (TFA)

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Histone H3 (1-35) (TFA)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.